Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7388 p203
18 February 2006

This article
Reprint   Photocopy

PDF 70K, Acrobat Reader

Letters

· SPCs
· Prescription pricing
· Oxygen supplies (6)
· The Journal
· Statins


Letters to the Editor

Prescription pricing

Independent and small group pharmacies are refusing to dispense expensive items

From Mr A. Sidhu, MRPharmS

I am seeing an increase in the number of prescriptions for expensive items (eg, norditropin) in the pharmacy I work for (Boots The Chemists). Many patients are informing me that other independent pharmacies have specifically told them that they will not dispense their prescription as it is too expensive for them to order. I may be wrong but is this not breaking our terms of service by refusing to dispense a prescription? Is there an ethical issue involved?

Imagine the scenario: “I am sorry madam but I cannot dispense your prescription since it is expensive for me to order. I will not get reimbursed for a few months and do not get a wholesale discount like the other chemist does. Perhaps you should go there.”

This conversation sounds preposterous as the patient is being told that they cannot be cared for because it is not financially viable.

If the current way that prescriptions are reimbursed by the Prescription Pricing Authority does not change, large multiples are better placed to provide care for patients if cost is an issue when deciding to dispense a prescription. Independent pharmacies are damaging the public’s perception of them and this in turn is damaging the profession as a whole. Why else do other professionals see us as money grabbers?

Amandip Sidhu
London

 

STEPHEN LUTENER, head of regulation at the Pharmaceutical Services Negotiating Committee, responds:

Paragraph 5 of the Pharmacists’ Terms of Service requires a pharmacy contractor to dispense with reasonable promptness, all prescriptions for medicines, unless they are scheduled drugs or one of the exceptions applies.

A sudden exceptional expensive prescription could cause serious cash flow problems for some pharmacy contractors. In this situation, we would recommend that pharmacy contractors contact their primary care trust and request an advance payment for that particular item, rather than waiting for payment via the normal payment cycle. It must be stressed, however, that such a decision would be discretionary for the PCT.

Send your letter to The Editor

Previous Topic (SPCs)
Next Topic (Oxygen supplies)

Back to Top


©The Pharmaceutical Journal